| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5587134 | Diabetes Research and Clinical Practice | 2017 | 24 Pages |
Abstract
This was the first observational study that compared DKA risk between new users of SGLT2i and non-SGLT2i AHAs among patients with type 2 diabetes, and overall no statistically significant difference was detected.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Yiting Wang, Mehul Desai, Patrick B. Ryan, Frank J. DeFalco, Martijn J. Schuemie, Paul E. Stang, Jesse A. Berlin, Zhong Yuan,